Pricing Log in Create free account
Friday 6 November 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue
+10.3%
EPS
+2,270.0%
Free cash flow
+9.97%
Total debt
+17.7%

Quarter to September 2026, against a year earlier

288.74 6.09 −2.07%
Market cap
$509.5B
P/E
49.7×
Fwd P/E
38.6×
Dividend yield
2.40%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

AbbVie Inc. (ABBV) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, AbbVie Inc. (ABBV) trades at a EV/EBITDA of 20.1×. Over the past ten years it has ranged from 8.2× (March 2020) to 28.7× (July 2015); the current reading is higher than 88% of that period. That is above the Drug Manufacturers General industry median of 14.8× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.4× 13.45%
FY2024 17.1× 33.36%
FY2023 12.8× (0.28%)
FY2022 12.9× 10.87%
FY2021 11.6× (19.32%)
FY2020 14.4× 36.44%
FY2019 10.5× (50.78%)
FY2018 21.4× 27.98%
FY2017 16.7× 33.69%
FY2016 12.5× (12.41%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 18.4× (7.39%)
Jun 2026 19.9× 7.51%
Mar 2026 18.5× (4.48%)
Dec 2025 19.4× (7.23%)
43 more quarters

Against its own ten years

Low 8.2× High 28.7×
Ten-year median 14.2×
Current reading's percentile 88

EV/EBITDA against peers

Company EV/EBITDA
PFE Pfizer Inc. compare 10.9×
AZN AstraZeneca PLC compare 14.8×
NVS Novartis AG compare 15.6×
AMGN Amgen Inc. compare 17.6×
ABBV AbbVie Inc. 20.1×
JNJ Johnson & Johnson compare 24.4×
MRK Merck & Co., Inc. compare 29.7×
LLY Eli Lilly and Company compare 34.4×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ABBV